Literature DB >> 10808046

IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis.

I Huitinga1, M van der Cammen, L Salm, Z Erkut, A van Dam, F Tilders, D Swaab.   

Abstract

Corticotropin-releasing hormone (CRH)-containing neurons in the paraventricular nucleus (PVN) in the hypothalamus of multiple sclerosis (MS) patients are hyperactivated. Since interleukin-1 (IL-1)beta is a powerful activator of CRH neurons, its immunohistochemical expression was studied in the postmortem hypothalamus of MS patients (n=11) and matched controls (n=11). Hypothalamic tissue of 10/11 MS patients showed demyelinating lesions that in many cases contained IL-1beta-immunoreactive (ir) macrophages and glial cells. In control subjects IL-1beta-ir was only sporadically found in glial cells. Interestingly, abundant IL-1beta-ir was also present in hypothalamic neurons. Neuronal IL-1beta co-localised with oxytocin and not with vasopressin or CRH. IL-1beta clearly yielded a less intense staining in neurons and numbers of IL-1-ir neurons in the PVN were 4.5-fold reduced in MS. We suggest that IL-1beta produced by activated glial cells in the hypothalamus of MS patients may contribute to the activation of the hypothalamic CRH neurons, while reduced expression of neuronal IL-1beta in MS patients may have consequences for neuroendocrine, behavioural or autonomic functioning.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808046     DOI: 10.1016/s0165-5728(00)00248-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

1.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

2.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

3.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

4.  Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

5.  Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

Authors:  Carina C Ferrari; Amaicha M Depino; Federico Prada; Nara Muraro; Sandra Campbell; Osvaldo Podhajcer; V Hugh Perry; Daniel C Anthony; Fernando J Pitossi
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 6.  Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.

Authors:  D S Kasatkin; N N Spirin
Journal:  Neurosci Behav Physiol       Date:  2007-03

7.  Interleukin-1β in Central Nervous System Injury and Repair.

Authors:  Nicole A Jackman; Robert J Claycomb; Sandra J Hewett
Journal:  Eur J Neurodegener Dis       Date:  2012-08

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

Authors:  Mark R Hutchinson; Susannah S Lewis; Benjamen D Coats; David A Skyba; Nicole Y Crysdale; Debra L Berkelhammer; Anita Brzeski; Alexis Northcutt; Christine M Vietz; Charles M Judd; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2008-10-04       Impact factor: 7.217

10.  CNTF receptor alpha is expressed by magnocellular neurons and expression is upregulated in the rat supraoptic nucleus during axonal sprouting.

Authors:  John A Watt; David Lo; Harwood J Cranston; Charles M Paden
Journal:  Exp Neurol       Date:  2008-10-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.